Software Healthcare Sector

MapLight Therapeutics

Market Cap: US$519.9m

Operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

Imricor Medical Systems

Market Cap: AU$720.7m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Senseonics Holdings

Market Cap: US$513.4m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

Evommune

Market Cap: US$508.8m

Operates as a clinical-stage biotechnology company in the United States.

BlossomHill Therapeutics

Market Cap: US$501.9m

A clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment.

Ginkgo Bioworks Holdings

Market Cap: US$498.3m

Develops a platform for cell engineering in the United States.

Vireo Growth

Market Cap: CA$685.0m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Relmada Therapeutics

Market Cap: US$493.9m

Operates as a clinical-stage biotechnology company in the United States.

C4 Therapeutics

Market Cap: US$492.1m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.

NRC Health

Market Cap: US$490.8m

Provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.

ProKidney

Market Cap: US$486.7m

A clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Prothena

Market Cap: US$485.1m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.

NeuroPace

Market Cap: US$481.6m

Operates as a medical device company in the United States.

Editas Medicine

Market Cap: US$477.6m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Puma Biotechnology

Market Cap: US$477.0m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Q32 Bio

Market Cap: US$475.4m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

Ocugen

Market Cap: US$471.4m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

ClearPoint Neuro

Market Cap: US$469.5m

A commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.

Benitec Biopharma

Market Cap: US$463.1m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Shoulder Innovations

Market Cap: US$459.3m

Designs, develops, manufactures, and distributes implant systems for shoulder arthroplasty in the United States.

EyePoint

Market Cap: US$458.6m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Sight Sciences

Market Cap: US$455.0m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States.

Verano Holdings

Market Cap: CA$626.0m

Engages in the cannabis business in the United States.

Canopy Growth

Market Cap: CA$617.6m

Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.

Eupraxia Pharmaceuticals

Market Cap: CA$612.9m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Nika Pharmaceuticals

Market Cap: US$441.7m

Engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States.

Allergy Therapeutics

Market Cap: UK£323.0m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.

Carlsmed

Market Cap: US$438.2m

A commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions.

Larimar Therapeutics

Market Cap: US$436.3m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Atea Pharmaceuticals

Market Cap: US$435.5m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Inhibikase Therapeutics

Market Cap: US$435.2m

Operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH), a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance.

BioAge Labs

Market Cap: US$435.1m

A clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases.

Avacta Group

Market Cap: UK£318.5m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

Compass Therapeutics

Market Cap: US$432.2m

A clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States.

Foghorn Therapeutics

Market Cap: US$419.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.